Letter: opioid usage is associated with rectal hyposensitivity in patients with opioid-induced constipation
- PMID: 36710538
- DOI: 10.1111/apt.17381
Letter: opioid usage is associated with rectal hyposensitivity in patients with opioid-induced constipation
Comment on
-
Incidence, pathophysiology, and implications of opioid-induced constipation and suggestions for patient-provider interactions.Aliment Pharmacol Ther. 2022 May;55 Suppl 2:S1-S7. doi: 10.1111/apt.16702. Aliment Pharmacol Ther. 2022. PMID: 35544278 Review. No abstract available.
References
REFERENCES
-
- Cash BD. Incidence, pathophysiology, and implications of opioid-induced constipation and suggestions for patient-provider interactions. Aliment Pharmacol Ther. 2022;55(Suppl 2):S1-7.
-
- Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J. 2019;7(1):7-20.
-
- Vollebregt PF, Burgell RE, Hooper RL, Knowles CH, Scott SM. Clinical impact of rectal hyposensitivity: a cross-sectional study of 2,876 patients with refractory functional constipation. Am J Gastroenterol. 2020;116:758-68.
-
- Nojkov B, Baker J, Menees S, Watts L, Collins K, Armstrong M, et al. Is dyssynergic defecation an unrecognized cause of chronic constipation in patients using opioids? Am J Gastroenterol. 2019;114:1772-7.
-
- Lodhia NA, Horton L, Thapa N, Goldin AH, Chan WW. Opioid-associated anorectal dysfunction in chronic constipation. Dig Dis Sci. 2022;67:3904-10.